30-Day Crosswalk

IPAY 2027 30-day to final NDE Process ICR_Crosswalk FINAL.docx

Drug Price Negotiation for Initial Price Applicability Year 2028 under Sections 11001 and 11002 of the Inflation Reduction Act (CMS-10849) - (IRA)

30-Day Crosswalk

OMB: 0938-1452

Document [docx]
Download: docx | pdf

Negotiation Data Elements and Drug Price Negotiation Process Information Collection Request (ICR) for Initial Price Applicability Year 2027

Crosswalk of Changes Between the 30-Day and Final Documents*

Location of Edits

Summary of Changes

(Included for 30-day Comment Period)

Type of Change

Explanation of Changes

Burden Change (Yes/No)

Supporting Statement


Background, Outside Consultation and Burden Estimates

  • Included discussion of final revisions

Modify

Technical Updates

No

Information Collection Request (ICR) Forms


ICR Form – Negotiation Data Elements


Section C

  • Revised instructions for Questions 1, 2b, 3d, 4c, and 5a regarding adjustments for inflation and cost of capital

  • Revised instructions for Questions 1, 2a, 3a, 4a, and 5c regarding adjustments for inflation and cost of capital

Modify

Revisions made in response to comments received from the ICR 30-Day Comment Period


No

Question 27

  • Instructions revised to clarify that respondent should list the applicable question numbers and also indicate which question the response applies to within the free text field

Modify

Technical Updates

No

Section I

  • Added clarifying instructions to Question 28 regarding the applicability of the options and sub-question regarding manufacturer affiliation for a Primary Manufacturer

  • Added clarification to instructions for patient- and caregiver-focused questions that respondents should address their experience related to the selected drug and its therapeutic alternatives

  • Revised title of Question 45 to include “Additional”

  • Revised instructions for Question 61 to specify that respondents will select, not click, applicable questions

Modify

Technical Updates and revisions made in response to comments received from the ICR 30-Day Comment Period


No

Question 62

  • Instructions revised to clarify that respondent should list the applicable question numbers and indicate which question the response applies to within the free text field

Modify

Technical Updates

No

ICR Form – Drug Price Negotiation Process


Question 1

  • Revised “counteroffer price” to “proposal for the MFP”

Modify

Technical Update

No

*Question numbering matches final document.

1

File Typeapplication/vnd.openxmlformats-officedocument.wordprocessingml.document
AuthorAllison Ruvidich
File Modified0000-00-00
File Created2025-11-25

© 2025 OMB.report | Privacy Policy